Drugs / Tachipirina®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06358586 | Apr 2022 | — | Angelini Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tachipirina | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06358586 ↗ |
| Route | Oral | “A single oral dose of the Tachipirina® 120 mg/5 mL oral suspension(10 mL) will be administered to healthy paediatric volunteers” NCT06358586 ↗ |